Showing results (301-310 of 315) with videos related to
Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2019
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trialO Trédan, Q Wang, D Pissaloux, et al.Journal of Gynecology Obstetrics and Human Reproduction|April 3, 2019
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)V Lavoue, C Huchon, C Akladios, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 26, 2019
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCaV Lavoue, C Huchon, C Akladios, et al.Journal of Gynecology Obstetrics and Human Reproduction|April 3, 2019
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathologyV Lavoue, C Huchon, C Akladios, et al.Gynecologie, Obstetrique, Fertilite & Senologie|February 2, 2019
[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)]V Lavoué, C Huchon, C Akladios, et al.Gynecologie, Obstetrique, Fertilite & Senologie|January 29, 2019
[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)]V Lavoué, C Huchon, C Akladios, et al.Nature Communications|September 23, 2024
Phase transition kinetics of superionic H2O ice phases revealed by Megahertz X-ray free-electron laser-heating experimentsR J Husband, H P Liermann, J D McHardy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2024
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJ A Ledermann, X Matias-Guiu, F Amant, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.Pageof 32